Dara-BCD for Rare MGRS
NCT06771180
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Monoclonal Gammopathy of Renal Significance (MGRS)
Interventions
DRUG:
Dara-CyBorD
Sponsor
Peking University People's Hospital